• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Ono Pharma submits marketing approval of metyrosine in Japan

biospectrumasiaMay 03, 2018

Tag: Ono Pharmaceutical , metyrosine , Japan , Valeant

Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) treatment metyrosine (ONO-5371), a tyrosine hydroxylase inhibitor licensed from Canada’s Valeant Pharmaceuticals International in October 2013, in Japan. 

This application is based on a multicenter, open-label, non-comparative study and its accompanying continuous administration study, Phase I/II study (ONO-5371-02), in patients with the symptoms associated with catecholamine excess secretion of pheochromocytoma, conducted in Japan. 

Valeant markets metyrosine under the trade name of Demser in the indication of PCC

Register as Visitor to CPhI China 2018!

Previous:Samsung BioLogics’ stock slides after regulators claim accounting rules infraction

Next:India’s drug regulatory force conducts third round of raids on manufacturers

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Ono Pharma submits marketing approval of metyrosine in Japan | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine
Desiccant use Japanese Paper

Desiccant use Japanese Paper
Japanese Pagodatree Flower-bud

Japanese Pagodatree Flower-bud
Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract
Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder

Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder
Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder

Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder
American standard Japanese standard German standard gate valve

American standard Japanese standard German standard gate valve
Desiccants use Japanese papaer

Desiccants use Japanese papaer
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service